RxDoctor Payments Data

Bernard Gasch, MD

Dermatology · Portland, ORNPI 1407851363

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,071 of the $4,710 with a category attached, or 86.4%. It is spread thinly across 29 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations.

$4,710in general payments, 2019–2025

Across 172 payments — averaging $27.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$753
  • Novartis$389
  • Regeneron Healthcare Solutions, Inc.$319
  • E.r. Squibb & Sons, L.L.C.$268
  • Pfizer$261
  • plus $2K from 23 others
$11,973in research payments, 2019–2025

Across 6 payments — averaging $1995.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$12K

What the payments were for

  • Food & beverage$4,07186%
  • Education$64014%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,710 in reported general payments places this provider in the 70th percentile of 175 dermatology providers in Oregon.

See all dermatology providers in Oregon

Medicare billing

Part B allowed, 2024
$108,243
Medicare patients
255
Services billed
3,612

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate153$6,226
Clobetasol Propionate96$4,332
Fluorouracil20$1,829
Dutasteride29$1,146
Ciclopirox27$896
Minoxidil66$873
Imiquimod25$865
Spironolactone26$600
Doxycycline Monohydrate14$594
CiclopiroxCiclopirox Olamine16$551
Finasteride63$544
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet17$489
ValacyclovirValacyclovir Hcl11$448
Doxepin Hcl17$337
Mupirocin19$201

Paid to pharmacies, not to this prescriber.

Other dermatology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →